{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-005840","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2026-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.563893+00:00","generated_at":"2026-05-16T03:38:59.700763+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Calidi Biotherapeutics posts updated corporate presentation; details unknown","bullets":["Company made updated presentation available on its website on February 6, 2026.","Presentation furnished as Exhibit 99.1 to this Form 8-K under Item 7.01 Regulation FD.","No specific financial or operational updates disclosed in the filing excerpt provided.","Presentation content not included in the available text; cannot assess material changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-005840","json":"https://secwatch.observer/filing/0001493152-26-005840.json","markdown":"https://secwatch.observer/filing/0001493152-26-005840.md","text":"https://secwatch.observer/filing/0001493152-26-005840.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226005840/0001493152-26-005840-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226005840/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:38:59.700763+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}